表紙
市場調査レポート

動物・家畜用ワクチンの世界市場予測 2020年

Veterinary, Animal Vaccines Market - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 281737
出版日 ページ情報 英文 186 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
動物・家畜用ワクチンの世界市場予測 2020年 Veterinary, Animal Vaccines Market - Global Forecast to 2020
出版日: 2015年06月09日 ページ情報: 英文 186 Pages
概要

世界の動物・家畜用ワクチン市場は2015年から2020年にかけて5.5%のCAGRで成長し、2015年の55億730万米ドルから2020年までに71億9,790万米ドルへ達する見込みです。

当レポートでは、世界の動物・家畜用ワクチン市場について調査分析し、製品、病種、技術、地域別に予測するほか、発展を推進・抑制する要因、成長への機会と課題、競合環境、主要参入企業など同市場についての最新情報をまとめ、お届けいたします。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 家畜用ワクチン市場は安定した割合で成長
  • 家畜用ワクチン市場:製品別
  • 家畜用ワクチン市場:地域別
  • 家畜用ワクチン市場:技術別
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
  • 市場セグメンテーション
    • 推進要因
    • 抑制要因
    • 機会

第6章 動物用ワクチン市場:製品別

  • イントロダクション

第7章 動物用ワクチン市場:疾病別

  • イントロダクション
  • ブタ用ワクチン:疾病別
  • ブタの疾病:概要
  • 家禽類用ワクチン:疾病別
  • 家禽類の疾病:概要
  • ペット用ワクチン:疾病別
  • イヌ用ワクチン:疾病別
  • イヌの疾病:概要
  • ネコ用ワクチン:疾病別
  • ネコの疾病:概要
  • 家畜用ワクチン:疾病別
  • ウシの疾病:概要
  • 小型反すう動物の疾病:疾病別
  • 小型反すう動物用ワクチン
  • ウマの疾病:概要
  • ウマ用ワクチン:疾病別
  • 水産養殖用ワクチン:疾病別
  • 水産養殖生物の疾病:概要

第8章 動物用ワクチン市場:技術別

  • イントロダクション
  • 弱毒化生ワクチン (LAV)
  • 不活化ワクチン
  • トキソイドワクチン
  • 組み換えワクチン
  • 共役ワクチン
  • サブユニットワクチン
  • DNAワクチン

第9章 動物用ワクチン市場:地域別

  • イントロダクション
  • 欧州
  • 北米
  • アジア
  • 中国
  • インド
  • その他 (RoW)
  • ブラジル

第10章 競合環境

  • 概要
  • 市場シェア分析
  • 家畜用ワクチン市場:主な発展、製品別
  • 競合状況・動向

第11章 企業プロファイル

  • イントロダクション
  • Bayer Healthcare
  • Bioniche Animal Health
  • Boehringer Ingelheim
  • Ceva Animal Health
  • Elanco Animal Health (Eli Lilly)
  • Heska Corporation
  • Merck Animal Healthcare
  • Merial Inc. (SANOFI)
  • Virbac
  • Zoetis

第12章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PH 3475

The report segments the veterinary vaccines market on the basis of products, diseases, technologies, and regions. On basis of products, the veterinary vaccines market is categorized into companion animal vaccines, livestock vaccine, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines. Among these, the companion animal vaccines segment is the fastest-growing segment due to increasing prevalence of zoonotic diseases in humans and growing pet population.

The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment is expected to witness highest growth in the forecast period.

New product launches and strategic collaborations were key strategies adopted by major industry players to increase their market share and cater to unmet needs. Emerging and immature markets such as the Middle East, Brazil, Argentina, Mexico, Turkey, China, and India are lucrative markets for veterinary vaccines, owing to favorable government initiatives.

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the veterinary vaccines market and the product portfolios, developments, and strategies adopted to maintain and increase their market shares. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios of the top players in the veterinary vaccines market. The report analyzes the veterinary vaccines market by product and geography
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the veterinary vaccines market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the veterinary vaccines market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various product across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the veterinary vaccines market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Scope
    • 1.3.1. Markets Covered
    • 1.3.2. Years Considered for the Study
  • 1.4. Currency
  • 1.5. Limitations
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Market Size Estimation
  • 2.2. Market Breakdown and Data Triangulation
    • 2.2.1. Key Data From Secondary Sources
    • 2.2.2. Key Data From Primary Sources
      • 2.2.2.1. Key Industry Insights
    • 2.2.3. Assumptions for the Study

3. Executive Summary

4. Premium Insights

  • 4.1. Veterinary Vaccines Market to Grow at A Steady Rate
  • 4.2. Veterinary Vaccines Market, By Product
  • 4.1. Veterinary Vaccines Market, By Region
  • 4.2. Veterinary Vaccines Market, By Technology
  • 4.3. Lifecycle Analysis, By Region

5. Market Overview

  • 5.1. Introduction
  • 5.2. Market Dynamics
    • 5.2.1. Drivers
      • 5.2.1.1. Rising Prevalence of Diseases in Animals
      • 5.2.1.2. Increasing Incidence of Zoonotic Diseases
      • 5.2.1.3. Increasing Investments By Various Government Agencies, Animal Associations, and Leading Players
      • 5.2.1.4. Introduction of New Types of Vaccines
    • 5.2.2. Restraints
      • 5.2.2.1. Rising Maintenance Costs for Storage of Vaccines
      • 5.2.2.2. Increasing Adoption of Vegetarian Food Across Major Economies
    • 5.2.3. Opportunities
      • 5.2.3.1. Technological Innovations Such as DNA Vaccines
      • 5.2.3.2. Growing Awareness of Animal Health in Emerging Economies

6. Veterinary Vaccines Market, By Product

  • 6.1. Introduction

7. Veterinary Vaccines Market, By Disease

  • 7.1. Introduction
  • 7.2. Porcine Vaccines, By Disease
  • 7.3. Porcine Diseases: Overview
  • 7.4. Poultry Vaccines, By Disease
  • 7.5. Poultry Diseases: Overview
  • 7.6. Companion Animal Vaccines, By Disease
  • 7.7. Canine Vaccines
  • 7.8. Canine Diseases: Overview
  • 7.9. Feline Vaccines
  • 7.10. Feline Diseases: Overview
  • 7.11. Livestock Vaccines, By Disease
    • 7.11.1. Bovine Vaccines
  • 7.12. Bovine Diseases: Overview
    • 7.12.1. Small Ruminant Vaccines, By Disease
  • 7.13. Samll Ruminant Diseases: Overview
  • 7.14. Equine Vaccines, By Disease
  • 7.15. Equine Diseases: Overview
  • 7.16. Aquaculture Vaccines, By Disease
  • 7.17. Aquaculture Diseases: Overview

8. Veterinary Vaccines Market, By Technology

  • 8.1. Introduction
  • 8.2. Live Attenuated Vaccines (LAV)
  • 8.3. Inactivated Vaccines
  • 8.4. Toxoid Vaccines
  • 8.5. Recombinant Vaccines
  • 8.6. Conjugate Vaccines
  • 8.7. Subunit Vaccines
  • 8.8. DNA Vaccines

9. Veterinary Vaccines Market, By Region

  • 9.1Introduction
  • 9.2. Europe
  • 9.3. North America
  • 9.4. Asia
  • 9.5. China
    • 9.5.1. Thailand
      • 9.5.1.1. Regulatory Landscape for Veterinary Vaccines in Thailand
  • 9.6. India
  • 9.7. Rest of the World (RoW)
  • 9.8. Brazil

10. Competitive Landscape

  • 10.1. Overview
  • 10.2. Market Share Analysis
  • 10.3. Veterinary Vaccines Market, Major Developments, By Product (2013-2015)
    • 10.3.1. Recent Developments By Market Players (2013-2015)
      • 10.3.1.1. Zoetis (Pfizer)
      • 10.3.1.2. Merck Animal Health
      • 10.3.1.3. Boehringer Ingelheim
      • 10.3.1.4. Ceva Animal Health
  • 10.4. Competitive Situation and Trends
    • 10.4.1. New Product Launches
    • 10.4.2. Agreements, Partnerships, and Collaborations
    • 10.4.3. Acquisitions
    • 10.4.4. Expansion
    • 10.4.5. Other Developments

11. Company Profiles

  • 11.1. 1.1. Introduction
  • 11.2. Bayer Healthcare
    • 11.2.1. Business Overview
    • 11.2.2. Product Portfolio
    • 11.2.3. Recent Developments
  • 11.3. Bioniche Animal Health
    • 11.3.1. Business Overview
    • 11.3.2. Product Portfolio
    • 11.3.3. Recent Developments
  • 11.4. Boehringer Ingelheim
    • 11.4.1. Business Overview
    • 11.4.2. Product Portfolio
    • 11.4.3. Recent Developments
    • 11.4.4. MnM View
  • 11.5. Ceva Animal Health
    • 11.5.1. Business Overview
    • 11.5.2. Product Portfolio
    • 11.5.3. Recent Developments
  • 11.6. Elanco Animal Health (Eli Lilly)
    • 11.6.1. Business Overview
    • 11.6.2. Product Portfolio
    • 11.6.3. Recent Developments
    • 11.6.4. MnM View
  • 11.7. Heska Corporation
    • 11.7.1. Business Overview
    • 11.7.2. Product Portfolio
    • 11.7.3. Recent Developments
  • 11.8. Merck Animal Healthcare
    • 11.8.1. Business Overview
    • 11.8.2. Product Portfolio
    • 11.8.3. Recent Developments
    • 11.8.4. MnM View
  • 11.9. Merial Inc. (SANOFI)
    • 11.9.1. Business Overview
    • 11.9.2. Product Portfolio
    • 11.9.3. Recent Developments
    • 11.9.4. MnM View
  • 11.10. Virbac
    • 11.10.1. Business Overview
    • 11.10.2. Product Portfolio
    • 11.10.3. Recent Developments
  • 11.11. Zoetis
    • 11.11.1. Business Overview
    • 11.11.2. Product Portfolio
    • 11.11.3. Recent Developments
    • 11.11.4. MnM View

12. Appendix

  • 12.1. Insights of Industry Experts
  • 12.2. Discussion Guide
  • 12.3. Other Developments
  • 12.4. Introducing RT: Real-Time Market Intelligence
  • 12.5. Available Customizations
  • 12.6. Related Reports

List of Tables

  • Table 1: Growing Incidence of Zoonotic Diseases to Drive the Animal Vaccines Market
  • Table 2: High Maintenance and Storage Cost of Vaccines to Restrain Market Growth
  • Table 3: Technological Advancements Likely to Boost the Veterinary Vaccines Market
  • Table 4: Animal Vaccines Market Size, By Product, 2013-2020 ($Million)
  • Table 5: Porcine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 6: Poultry Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 7: Canine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 8: Feline Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 9: Bovine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 10: Small Ruminant Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 11: Equine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 12: Aquaculture Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 13: Animal Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 14: Live Attenuated Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 15: Inactivated Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 16: Toxoid Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 17: Recombinant Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 18: Conjugate Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 19: Subunit Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 20: DNA Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 21: Animal Vaccines Market Size, By Region, 2013-2020 ($Million)
  • Table 22: Europe: Veterinary Vaccines Market Size, By Product, 2013-2020 ($Million)
  • Table 23: Europe: Porcine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 24: Europe: Porcine Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 25: Europe: Livestock Vaccines Market Size, By Category, 2013-2020 ($Million)
  • Table 26: Europe: Bovine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 27: Europe: Small Ruminant Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 28: Europe: Livestock Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 29: Europe: Poultry Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 30: Europe: Poultry Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 31: Europe: Companion Animal Vaccines Market Size, By Category, 2013-2020 ($Million)
  • Table 32: Europe: Canine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 33: Europe: Feline Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 34: Europe: Companion Animal Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 35: Europe: Equine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 36: Europe: Equine Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 37: Europe: Aquaculture Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 38: Europe: Aquaculture Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 39: North America: Animal Vaccines Market Size, By Product, 2013-2020 ($Million)
  • Table 40: North America: Porcine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 41: North America: Porcine Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 42: North America: Livestock Vaccines Market Size, By Category, 2013-2020 ($Million)
  • Table 43: North America: Bovine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 44: North America: Small Ruminant Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 45: North America: Livestock Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 46: North America: Poultry Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 47: North America: Poultry Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 48: North America: Companion Animal Vaccines Market Size, By Category, 2013-2020 ($Million)
  • Table 49: North America: Canine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 50: North America: Feline Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 51: North America: Companion Animal Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 52: North America: Equine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 53: North America: Equine Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 54: North America: Aquaculture Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 55: North America: Aquaculture Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 56: China: Animal Vaccines Market Size, By Product, 2013-2020 ($Million)
  • Table 57: China: Porcine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 58: China: Porcine Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 59: China: Livestock Vaccines Market Size, By Category, 2013-2020 ($Million)
  • Table 60: China: Bovine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 61: China: Small Ruminant Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 62: China: Livestock Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 63: China: Poultry Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 64: China: Poultry Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 65: China: Companion Animal Vaccines Market Size, By Category, 2013-2020 ($Million)
  • Table 66: China: Canine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 67: China: Feline Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 68: China: Companion Animal Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 69: China: Equine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 70: China: Equine Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 71: China: Aquaculture Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 72: China: Aquaculture Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 73: Thailand: Veterinary Vaccines Market Size, By Product, 2013-2020 ($Million)
  • Table 74: Thailand: Porcine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 75: Thailand: Porcine Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 76: Thailand: Poultry Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 77: Thailand: Poultry Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 78: Thailand: Companion Animal Vaccines Market Size, By Category, 2013-2020 ($Million)
  • Table 79: Thailand: Canine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 80: Thailand: Feline Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 81: Thailand: Companion Animal Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 82: Thailand: Livestock Animal Vaccines Market Size, By Category, 2013-2020 ($Million)
  • Table 83: Thailand: Bovine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 84: Thailand: Small Ruminant Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 85: Thailand: Livestock Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 86: India: Animal Vaccines Market Size, By Product, 2013-2020 ($Million)
  • Table 87: India: Porcine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 88: India: Porcine Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 89: India: Livestock Vaccines Market Size, By Category, 2013-2020 ($Million)
  • Table 90: India: Bovine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 91: India: Small Ruminant Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 92: India: Livestock Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 93: India: Poultry Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 94: India: Poultry Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 95: India: Companion Animal Vaccines Market Size, By Category, 2013-2020 ($Million)
  • Table 96: India: Canine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 97: India: Feline Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 98: India: Companion Animal Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 99: India: Equine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 100: India: Equine Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 101: India: Aquaculture Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 102: India: Aquaculture Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 103: Brazil: Veterinary Vaccines Market Size, By Product, 2013-2020 ($Million)
  • Table 104: Brazil: Porcine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 105: Brazil: Porcine Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 106: Brazil: Livestock Vaccines Market Size, By Category, 2013-2020 ($Million)
  • Table 107: Brazil: Bovine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 108: Brazil: Small Ruminant Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 109: Brazil: Livestock Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 110: Brazil: Poultry Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 111: Brazil: Poultry Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 112: Brazil: Companion Animal Vaccines Market Size, By Category, 2013-2020 ($Million)
  • Table 113: Brazil: Canine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 114: Brazil: Feline Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 115: Brazil: Companion Animal Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 116: Brazil: Equine Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 117: Brazil: Equine Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 118: Brazil: Aquaculture Vaccines Market Size, By Disease, 2013-2020 ($Million)
  • Table 119: Brazil: Aquaculture Vaccines Market Size, By Technology, 2013-2020 ($Million)
  • Table 120: New Product Launches, 2013-2015
  • Table 121: Agreements, Partnerships, and Collaborations, 2013-2015
  • Table 122: Acquisitions, 2013-2015
  • Table 123: Expansions, 2013-2015
  • Table 124: Other Developments, 2012-2015

List of Figures

  • Figure 1: Research Design: Veterinary Vaccines Market
  • Figure 2: Market Size Estimation
  • Figure 3: Breakdown of Primary Interviews: By Company Type, Designation, and Region
  • Figure 4: Data Triangulation Methodology
  • Figure 5: Animal Vaccines Market Snapshot (2015 vs. 2020): Companion Animal Vaccines Segment to Grow at the Highest CAGR
  • Figure 6: Live Attenuated Vaccines Segment is Expected to Dominate the Animal Vaccines Technologies Market in 2015
  • Figure 7: Asia-Pacific Market to Witness the Highest Growth During the Forecast Period
  • Figure 8: Figure 1 Attractive Market Opportunities
  • Figure 9: Porcine Vaccines Segment Accounted for the Largest Share in 2014
  • Figure 10: Asia is Expected to Be the Fastest-Growing Region During the Forecast Period
  • Figure 11: Live Attenuated Vaccines Technology Segment is Expected to Dominate the Animal Vaccines Market During the Forecast Period
  • Figure 12: Increasing Incidence of Zoonotic Diseases to Boost Market Growth
  • Figure 13: Porcine Vaccines Commanded Largest Share of the Veterinary Vaccines Market in 2014
  • Figure 14: Porcine Circovirus Segment Projected to Grow at Highest Rate in Porcine Vaccines Market, By 2020
  • Figure 15: Infectious Bronchitis Segment Dominated the Poultry Vaccines Market in 2014
  • Figure 16: Canine Distemper Segment Projected to Grow at Highest Rate in Canine Vaccines Market By 2020
  • Figure 17: Feline Rabies Segment Dominated Feline Vaccines Market in 2014
  • Figure 18: BVD Segment Projected to Grow at Highest Rate in Bovine Vaccines Market By 2020
  • Figure 19: Clostridial Diseases Segment Dominated the Small Ruminant Vaccines Market in 2014
  • Figure 20: Equine Rhinopneumonitis Segment Projected to Grow at Highest Rate in Equine Vaccines Market By 2020
  • Figure 21: Vibriosis Segment Dominated the Aquaculture Vaccines Market in 2014
  • Figure 22: Live Attenuated Vaccines Dominated the Global Animal Vaccines Market in 2014
  • Figure 23: Poultry Vaccines Dominated the Live Attenuated Vaccines Market in 2014
  • Figure 24: Companion Animal Vaccines to Witness the Highest Growth Rate in the Inactivated Vaccines Market By 2020
  • Figure 25: Livestock Vaccines Dominated the Toxoid Vaccines Market in 2014
  • Figure 26: Porcine Vaccines to Grow at the Highest Rate in the Recombinant Vaccines Market By 2020
  • Figure 27: Porcine Vaccines Dominated the Conjugate Vaccines Market in 2014
  • Figure 28: Livestock Vaccines to Grow at the Highest Rate in the Subunit Vaccines Market By 2020
  • Figure 29: Porcine Vaccines Dominated the DNA Vaccines Market in 2014
  • Figure 30: Geographic Snapshot Asia to Witness the Highest Growth in the Forecast Period
  • Figure 31: Asia, an Attractive Destination for All Product Categories
  • Figure 32: Europe Will Continue to Lead the Global Veterinary Vaccines Market in the Forecast Period
  • Figure 33: The Demand for Animal Vaccines Will Be Driven By the Growing Production of Pig Meat in the Forecast Period
  • Figure 34: The Porcine Vaccines Segment Accounted for the Largest Share of the European Veterinary Vaccines Market, By Product
  • Figure 35: Recombinant Vaccines Technology Will Be the Fastest-Growing Segmenting European Veterinary Vaccines Market in the Forecast Period
  • Figure 36: The Inactivated Vaccines Technology Segment Accounted for the Largest Share of the European Companion Animal Vaccines Market
  • Figure 37: The Live Attenuated Vaccines Technology Segment Accounted for the Largest Share of the North America Livestock Vaccines Market
  • Figure 38: Asia Market Snapshot: the Demand for Veterinary Vaccines Will Be Driven By Increasing Incidences of Zoonotic Diseases
  • Figure 39: The Livestock Vaccines Segment Accounted for the Largest Share of the Veterinary Vaccines Market in China
  • Figure 40: Conjugate Vaccines Technology Will Be the Fastest-Growing Segment for Asian Animal Vaccines Market in the Forecast Period
  • Figure 41: The Porcine Vaccines Segment Accounted for the Largest Share of the Thailand Veterinary Vaccines Market
  • Figure 42: Recombinant Vaccine Technology Segment to Witness the Highest Growth Thailand Veterinary Vaccines Market in the Forecast Period
  • Figure 43: The Livestock Vaccines Segment Accounted for the Largest Share of the Animal Vaccines Market in India
  • Figure 44: Conjugate Vaccines Technology Segment to Witness the Highest Growth in Livestock Vaccines Market the Forecast Period
  • Figure 45: The Poultry Vaccines Segment Accounted for the Largest Share of the Animal Vaccines Market in Brazil
  • Figure 46: Inactivated Vaccines Technology Segment to Grow at the Highest CAGR in Poultry Vaccines Market in the Forecast Period
  • Figure 47: Companies Adopted New Product Launches and Licenses as Their Key Growth Strategy (2013-2015)
  • Figure 48: Global Animal Vaccines Market Share, By Key Player, 2014
  • Figure 49: Animal Vaccines Market, Major Developments (2013-2015)
  • Figure 50: Zoetis (Pfizer) Focused on Porcine Segment in Last Few Years (2013-2015)
  • Figure 51: Merck Concentrated on Livestock Segment (2013-2015)
  • Figure 52: Boehringer Ingelheim Mainly Concentrated on Equine Segment (2013-2015)
  • Figure 53: Ceva Released New Products for the Poultry Segment (2013 - 2015)
  • Figure 54: Battle for Market Share: New Product Launches Was the Key Growth Strategy
  • Figure 55: Geographic Revenue Mix of Top Five Market Players
  • Figure 56: Bayer Healthcare: Company Snapshot
  • Figure 57: Bioniche Animal Health: Company Snapshot
  • Figure 58: Boehringer Ingelheim: Company Snapshot
  • Figure 59: Ceva Animal Health: Company Snapshot
  • Figure 60: Elanco Animal Health: Company Snapshot
  • Figure 61: Heska Corporation: Company Snapshot
  • Figure 62: Merck Animal Healthcare: Company Snapshot
  • Figure 63: Merial Inc. (SANOFI): Company Snapshot
  • Figure 64: Virbac: Company Snapshot
  • Figure 65: Zoetis: Company Snapshot
Back to Top